Li et al. showed that polyethylene glycolated (PEGylated) 17i nanoassemblies were superior to the KDM1A inhibitor compound 17i in terms of therapeutic efficiency, anti-tumor immune response, and systemic toxicity in xenografted CRC mice [182]. The gene discussed is KDM1A; the disease is colorectal carcinoma.